CXCL12 and breast carcinoma: Several studies have shown how acquisition of the chemokine receptor CXCR4 by breast cancer cells can promote specific, chemotactic recruitment to remote sites such as the bone marrow, lymph nodes, liver and lung in response to localised expression of the specific chemokine ligand, CXCL12 [133].